Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 18, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
NIGHTSEA SFA Propels Expansion of Economical Fluorescence
Friday, October 04, 2013
Easy-to-use Stereo Microscope Fluorescence Adapter for stereo imaging, simple sorting, and fluorescence-assisted dissection.

Improving Overall Growth & Performance of Primary Neurons
Tuesday, September 24, 2013
GS21 from AMSBIO improves long-term viability of rat and mouse primary neurons in vitro.

Almac Launches Reusable Shipper Option for Temperature-Controlled Distribution
Friday, September 20, 2013
Reusable shippers greatly improve environmental impact and provide cost efficiencies.

Easier, More Efficient DNA and siRNA Transfection
Wednesday, September 18, 2013
New ScreenFectA, now available from Alpha Laboratories.

Interactive Flip-Book Catalogue of Sample Storage Tubes & Accessories
Tuesday, September 17, 2013
New 130-page 2013 Interactive Flip-Book from Micronic.

Highly Purified Chondroitinase ABC from AMSBIO
Monday, September 16, 2013
Launch of new enzyme for neuroscience and regenerative medicine research.

Nanion Introduces New Product Family
Thursday, September 12, 2013
CardioExcyte 96 for cardiac toxicity profiling and screening.

CeMM and Haplogen Make Available the World’s Largest Collection of Human Cell Lines
Monday, September 02, 2013
Haplogen and CeMM partnership will distribute requested cell lines to the research community.

Energy Efficient Freeze Drying Enhances Pharmaceutical Production
Monday, August 19, 2013
New technical brief from SP Scientific on Hull freeze drying systems.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 454
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv